Cargando…
Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy
BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart fa...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319833/ https://www.ncbi.nlm.nih.gov/pubmed/32617488 http://dx.doi.org/10.1093/ehjcr/ytaa088 |
_version_ | 1783551127558553600 |
---|---|
author | Aouate, David Menet, Aymeric Bellevre, Dimitri Damy, Thibaud Marechaux, Sylvestre |
author_facet | Aouate, David Menet, Aymeric Bellevre, Dimitri Damy, Thibaud Marechaux, Sylvestre |
author_sort | Aouate, David |
collection | PubMed |
description | BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). DISCUSSION: The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation. |
format | Online Article Text |
id | pubmed-7319833 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-73198332020-07-01 Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy Aouate, David Menet, Aymeric Bellevre, Dimitri Damy, Thibaud Marechaux, Sylvestre Eur Heart J Case Rep Case Series BACKGROUND: Cardiac amyloidosis involvement is associated with a detrimental outcome including frequent arrhythmias, heart failure, and conduction disturbances which may need permanent pacing. CASES SUMMARY: We report two cases of patients with transthyretin amyloidosis (ATTR) who developed heart failure and depressed left ventricular ejection fraction (LVEF) following permanent right ventricular (RV) pacing but highly responded to cardiac resynchronization therapy (CRT). DISCUSSION: The impact of RV pacing and CRT in cardiac amyloidosis is not known. In our cases, the detrimental effect of permanent RV pacing on left ventricular (LV) systolic function and heart failure symptoms was suggested by both permanent RV pacing mediated functional and LV function decline and LV systolic dysfunction reversal following CRT along with QRS width reduction. Whether cardiac resynchronization should be readily recommended in ATTR patients who need ventricular pacing whatever the LVEF deserves further investigation. Oxford University Press 2020-05-01 /pmc/articles/PMC7319833/ /pubmed/32617488 http://dx.doi.org/10.1093/ehjcr/ytaa088 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Case Series Aouate, David Menet, Aymeric Bellevre, Dimitri Damy, Thibaud Marechaux, Sylvestre Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title | Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title_full | Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title_fullStr | Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title_full_unstemmed | Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title_short | Deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
title_sort | deleterious effect of right ventricular pacing in patients with cardiac transthyretin amyloidosis: potential clinical benefit of cardiac resynchronization therapy |
topic | Case Series |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319833/ https://www.ncbi.nlm.nih.gov/pubmed/32617488 http://dx.doi.org/10.1093/ehjcr/ytaa088 |
work_keys_str_mv | AT aouatedavid deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy AT menetaymeric deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy AT bellevredimitri deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy AT damythibaud deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy AT marechauxsylvestre deleteriouseffectofrightventricularpacinginpatientswithcardiactransthyretinamyloidosispotentialclinicalbenefitofcardiacresynchronizationtherapy |